基于聚合物的药物输送系统用于癌症治疗药物
Ling Ding1, Prachi Agrawal2, Sandeep K Singh1
1Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Polymers
|March 28, 2024
概括
本综述探讨了用于癌症化疗的基于聚合物的药物递送系统,突出了它们克服副作用和提高治疗疗效的潜力. 这些先进的平台提供了化学疗法药物的增强向和受控释放.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 化疗是癌症治疗的基石,通常与手术或放射治疗相结合.
- 化疗面临的挑战是由于非目标效应,导致副作用和剂量限制.
- 新型药物输送平台对于改善癌症治疗结果至关重要.
研究的目的:
- 审查影响化疗药物输送成功的障碍.
- 突出最近在天然和合成聚合物基础的癌症治疗输送系统的进展.
- 讨论这些平台在加强药物交付和克服治疗障碍方面的潜力.
主要方法:
- 对癌症治疗中基于聚合物的药物输送系统的当前文献的综述.
- 对药物载体应用的聚合物特性 (生物降解性,生物相容性,稳定性) 的分析.
- 检查药物加载和释放机制 (物理吸附,化学结合,内部加载).
主要成果:
- 聚合物提供了增强的药理动力学特征和选择性向癌细胞.
- 可生物降解,生物相容和稳定的聚合物是药物输送载体的理想选择.
- 聚合物平台可以控制化学治疗剂的释放,提高疗效和降低毒性.
结论:
- 仿生和生物启发的聚合物系统代表了有效的癌症化疗的有希望的未来.
- 这些平台有可能克服当前药物输送策略的重大挑战.
- 进一步开发基于聚合物的输送系统可以显著提高癌症治疗选择.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drug Delivery: Overview
290
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
290
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


